Atlas Genetics Raises $20M in Series C Financing | GenomeWeb

NEW YORK (GenomeWeb) – Molecular diagnostics firm Atlas Genetics today announced the completion of a Series C financing round that raised $20 million. 

Atlas will use the proceeds to accelerate the launch of its MDx system called io in Europe for the ultra-rapid diagnosis of infectious diseases, initiate clinical trials in the US, and expand its test menu for sexually transmitted diseases and hospital-acquired infections. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.